Clinical Trials Browser

Active not recruiting × Has announcements × Erlotinib Hydrochloride × Clear all

NCT02411448 2026-01-16

RELAY

Phase 3 Active not recruiting

545 enrolled 24 charts 1 FDA

Carcinoma, Non-Small-Cell Lung